gwb | Grubman Warner Berry

Search results for: false claims act

Judge gavel on desk

False Claims Act & Whistleblower Defense

The False Claims Act (FCA) is one of the federal government’s most powerful fraud-fighting tools. Each year, the federal government recovers billions of dollars in judgments and settlements under the FCA. While the majority of FCA investigations and litigation involve businesses and individuals within the healthcare industry, any individual or company that does business with […]

Read More
Stethoscope

Healthcare Fraud Investigations & Defense

If you are a healthcare provider, facing a government investigation can be stressful, costly, and disruptive to your practice. Investigations often arise suddenly and move quickly, exposing targets to the potential for criminal, civil, and administrative consequences. We represent healthcare providers of all types and sizes in connection with government investigations, whether criminal, civil, or […]

Read More
Person reviewing investigation documents

Government Investigations

Each year, the federal and state governments spend tens of millions of dollars investigating allegations of healthcare fraud, waste, and abuse.  And in return, those government entities recover billions of dollars from healthcare providers in settlements and judgments, thus perpetuating an ever-increasing level of government enforcement within the healthcare industry. Not only does the government […]

Read More
Doctor consulting with patient

Healthcare

Healthcare is one of the largest and most heavily regulated industries in the United States. Healthcare providers face constant scrutiny by government investigators and regulators, commercial insurance companies, competitors, and potential whistleblowers, among other legal and regulatory risks. We Have Your Back For decades, GWB attorneys have represented and advised healthcare providers of all types […]

Read More

Aircraft-Component Suppliers and Owner Agree to Pay $1 Million to Resolve Buy American Act False Claims Act Allegations

On October 8, 2026, the U.S. Attorney’s Office for the Middle District of Alabama announced that Ranga Ranganathan, Nielsen Hardware Corporation, and J&P Khamken Industries, Inc. agreed to pay $1 million to resolve allegations that they supplied the Department of War with Chinese-manufactured products and components in violation of the Buy American Act and federal […]

Read More

CVS Agrees to Pay $315 Million to Resolve Opioid Dispensing and False Claims Act Allegations

On October 13, 2026, the Department of Justice announced that CVS Pharmacy Inc. and related entities agreed to pay $315 million to resolve allegations that they unlawfully filled prescriptions for opioids and other controlled substances and then sought payment for many of those prescriptions from Medicare and other federal healthcare programs. The resolution consists of […]

Read More

Frazier Aviation Former Chief Executive Agrees to Pay $4.9 Million to Resolve Aircraft Parts False Claims Act Allegations

On September 29, 2026, the U.S. Attorney’s Office for the Eastern District of Virginia announced that Frazier Aviation Inc. and its former chief executive agreed to resolve False Claims Act (FCA) allegations involving aircraft parts sold to the federal government. The former chief executive will pay $4.9 million to the United States. The government alleged […]

Read More

United States Files False Claims Act Lawsuit Against Texas Physician Over Alleged Neurostimulator Billing

On September 29, 2026, the U.S. Attorney’s Office for the Southern District of Texas announced that they filed a False Claims Act (FCA) lawsuit against Dr. Michael Neret alleging that he billed Medicare nearly $500,000 for surgical neurostimulator electrode implantations that were not performed. According to the complaint, the billed surgical neurostimulator implantation procedures require […]

Read More

Independence Blue Cross Agrees to Pay $22.5 Million to Resolve Medicare Advantage False Claims Act Allegations

The Department of Justice (DOJ) has announced that Independence Blue Cross (IBX) has agreed to pay $22.5 million to resolve allegations that it submitted inaccurate diagnosis codes for Medicare Advantage (MA) enrollees and failed to correct codes that its own chart reviews did not substantiate. MA plans receive monthly payments that are adjusted in part […]

Read More

DOJ Revises False Claims Act Policies: New Limits on Guidance and Greater Scrutiny of Qui Tam Cases

On September 18, 2026, the Department of Justice (“DOJ”) announced revisions to the Justice Manual, addressing two significant issues in False Claims Act (“FCA”) enforcement: the government’s use of agency guidance documents in enforcement actions and DOJ’s authority to seek dismissal of qui tam lawsuits brought by whistleblowers. Although DOJ characterized the revisions as strengthening […]

Read More

DME Supplier and Owners Pay $825,000 to Resolve False Claims Act Case

On September 21, 2026, the United States Attorney’s Office for the Northern District of Georgia announced that Durable Medical Equipment (DME) supplier Crown Medical Solutions and its owners, Michelle and Philanzo King, had agreed to pay $825,000 to resolve allegations that they submitted false claims to Medicare for DME that was allegedly medically unnecessary or […]

Read More

Government Contractor Agrees to $25 Million False Claims Act Settlement Related to DEI Practices

On September 14, 2026, the DOJ announced that government tech contractor Accenture Federal Services and related companies had agreed to pay $25 million to resolve allegations that they violated the False Claims Act (FCA) by falsely certifying compliance with anti-discrimination requirements in its contracts while considering race or sex in certain employment decisions. The government […]

Read More

Honeywell Aerospace Agrees to Pay $2.04 Million to Resolve False Claims Act Allegations Involving Defense Contract Cybersecurity Requirements

The Department of Justice (DOJ) has announced that Honeywell Aerospace Inc. agreed to pay over $2 million to resolve allegations that it was liable under the False Claims Act (FCA) for failing to comply with cybersecurity requirements in a Department of Defense contract. The government alleged that a Honeywell International business unit submitted false claims […]

Read More

Deloitte Pays $21.5 Million to Resolve DEI-Related False Claims Act Case

On August 25, 2026, the Department of Justice (DOJ) announced that professional services firm Deloitte had agreed to pay $21.5 million to resolve allegations that several of its “DEI” employment practices violated federal anti-discrimination requirements incorporated into government contracts and, by extension, the False Claims Act (FCA). According to the government’s press release, Deloitte’s federal […]

Read More

Massachusetts Ophthalmology Practice Agrees to Pay $3.9 Million to Resolve False Claims Act Matter Involving Modifier 25 Billing

The U.S. Attorney’s Office for the District of Massachusetts recently announced that Ophthalmic Consultants of Boston, Inc. (OCB) agreed to pay $3,902,588.28 to resolve federal and state False Claims Act (FCA) claims involving office-visit billing on the same day as intravitreal injections. OCB is a multispecialty ophthalmology practice with locations throughout Massachusetts. The matter arose […]

Read More

Two New York Ophthalmology Practices Agree to Pay $2.3 Million to Resolve False Claims Act Allegations Involving Cranial Ultrasounds and Kickbacks

The Department of Justice (DOJ) has announced that two Florida-based ophthalmology practices—Fromer Eye Centers and Floral Park Ophthalmology P.C.—agreed to pay a total of $2.3 million to resolve allegations that they violated the False Claims Act (FCA) by billing Medicare and Medicaid for medically unnecessary trans-cranial doppler ultrasounds (TCDs) through an arrangement with a third-party […]

Read More

Medicare Advantage Provider Agrees to Pay $14.1 Million to Resolve False Claims Act Allegations Involving Unsupported Diagnosis Codes

The Department of Justice (DOJ) has announced that Florida-based management services organization Complete Health Partners Holdings agreed to pay $14.1 million to resolve allegations that it violated the False Claims Act (FCA) by causing false diagnosis codes to be submitted to the Medicare Advantage program.  According to the government, Complete Health’s contracts with Medicare Advantage […]

Read More

Texas Laboratory, Former CEO, and Florida Businessman Agree to Pay $36.4 Million to Resolve False Claims Act Allegations Involving Kickbacks and Unnecessary Genetic Testing

The Department of Justice (DOJ) has announced that Access DX Laboratory, its former CEO Michael Stewart, and Florida businessman Harold Shatz entered into civil settlements totaling $36.4 million to resolve allegations that they violated the False Claims Act (FCA) by paying kickbacks and caused Medicare and Medicaid to pay for medically unnecessary genetic testing. According […]

Read More

Kentucky Addiction Treatment Provider Agrees to $16.2 Million Civil Judgment to Resolve False Claims Act Allegations Involving Medicaid Billing

The U.S. Attorney’s Office for the Eastern District of Kentucky has announced that Addiction Recovery Care, LLC (ARC) and related entities, had agreed to a $16,205,774.05 civil judgment resolving allegations that they violated the False Claims Act (FCA) through improper Kentucky Medicaid billing. ARC operates residential and outpatient drug rehabilitation facilities throughout Kentucky, and the […]

Read More

New York Ethics Opinion Warns Lawyers Against Directing Deceptive Investigations in False Claims Act Cases

The New York State Bar Association’s Committee on Professional Ethics recently issued an opinion concluding that a private attorney may not induce, assist, or supervise a client’s use of deception to gather evidence for a potential False Claims Act (FCA) lawsuit. The opinion addresses an important issue for attorneys representing prospective whistleblowers: although covert investigative […]

Read More

Get in Touch With Us

For more information or to arrange a consultation, please contact us by telephone at (404) 233-4171 or online by submitting the form below. The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship nor create an expectancy of a potential attorney-client relationship. Do not submit information which is confidential or time sensitive, as it may not be treated as such.